Among patients with type 2 diabetes and peripheral artery disease or foot ulcers, the use of semaglutide is linked to a ...

Diabetic foot ulcer recurrence may now be more predictable due to a study that identifies compromised skin barrier function ...

Hyperbaric oxygen therapy improves diabetic foot ulcer healing but raises amputation risk. Careful clinical use is advised.

Growth factors like epidermal and platelet-derived types showed strong benefits in accelerating healing and reducing ...

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in ...

Severity stage classification of diabetic foot ulcers is a vital way to improve the decision support on treatment planning and diagnostic performance. Nevertheless, the precise manual identification ...

Diabetic foot ulcer (DFU) are a severe complication in diabetic patients, requiring accurate and early diagnosis to prevent further complications such as infection or amputation. To address this, ...

High transepidermal water loss with a cutoff of 30.05 g/m2/h was associated with a higher risk for diabetic foot ulcer recurrence.

Mumbai, India-based Ipca Laboratories Ltd has launched esmolol hydrochloride, branded as Diulcus, a drug for treatment of diabetic foot ulcers. Diulcus is a drug developed and patented by Indian firm ...